Durable Schistosome induced metabolic alterations to the myeloid lineage
Durable Schistosome induced metabolic alterations to the myeloid lineage
批准号:
10366064
负责人:
Eyal Amiel
金额:
$59.32万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-03-05 至 2025-02-28
关键词:
AddressAnti-Inflammatory AgentsAntiatherogenicAntigensApolipoprotein EAreaAsthmaAtherosclerosisBone MarrowCardiovascular DiseasesCardiovascular systemCellsCholesterolCholesterol HomeostasisChronicDataDependenceDevelopmentDiabetes MellitusDifferentiation AntigensDiseaseEstrogensFemaleFormulationGeneticGenetic TranscriptionGenomicsGlucose IntoleranceGoalsGonadal Steroid HormonesHelminthsHepaticHigh Fat DietImmunologicsInfectionInflammatoryInflammatory Bowel DiseasesInflammatory ResponseInsulinInsulin ResistanceInterleukin-4LeadLinkLipidsLiteratureMacrophage ActivationMapsMetabolicMetabolic DiseasesMetabolic syndromeMetabolismModelingModificationMorbidity - disease rateMusMyelogenousMyeloid Progenitor CellsNematodaObesityOxygen ConsumptionPathologyPathway interactionsPatientsPhenotypePhospholipid MetabolismPhospholipidsPopulationPrincipal Component AnalysisProgesteroneRecording of previous eventsResearchResolutionRiskRisk FactorsRoleSchistosomaSchistosoma mansoniTestingTestosteroneTranscription Alterationamino acid metabolismbiological sexcardiovascular disorder riskchronic inflammatory diseasecytokinediabeticdiabetic patienthelminth infectionhematopoietic differentiationimmune functionimmunoregulationinnovationinsulin sensitivitymacrophagemalemonocytemortalitymouse modelnon-diabeticnovelnovel strategiesprogenitorprotective effectrespiratorystem cell nichesuccesstherapy developmenttranscriptometranscriptomics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Diabetic patients have a two-fold greater risk of developing cardiovascular disease than non-diabetic subjects,
and more than 65% of diabetic patients die from cardiovascular complications, thus, there is a critical need for
novel approaches to targeting insulin resistance, obesity, and atherosclerosis in this population. Recent
evidence has suggested that innate and/or adaptive inflammatory responses are associated with both insulin
resistance and obesity, while atherosclerosis is now widely accepted to be a lipid-dependent chronic
inflammatory disease. An increasing body of literature has established an inverse correlation between chronic
helminth infections and metabolic syndrome/diabetes. The central hypothesis of this project is that
schistosome antigenic exposure induces long-lived modifications in the monocyte/macrophage lineage that
lead to profound alterations in systemic phospholipid, cholesterol, and amino acid metabolism, resulting in a
protective state from the detrimental effects of High Fat Diet (HFD) (e.g., insulin insensitivity, and
atherosclerosis). The rationale for this research is that identifying genetic drivers that underlie this protective
phenotype is expected to enable the formulation and development of therapies to target these pathways as
treatments for diabetic patients at risk for CVD. This objective will be addressed by pursuing three specific
aims: 1) Define the role of S. mansoni infection in regulating the long-term metabolic and immunological
function of macrophages; 2) Determine how S. mansoni infection regulates hematopoietic differentiation of
macrophages at the transcriptional level; and 3) Determine the role of biological sex and sex hormones in
schistosome induced metabolic reprogramming. It is expected that the findings from these studies will provide
a definitive conceptual framework as to the mechanism through which S. mansoni infection modulates
metabolism and immunologic plasticity of the macrophage lineage.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Durable Schistosome induced metabolic alterations to the myeloid lineage
-
批准号:10184936
-
项目类别:
-
资助金额:$62.7万
-
财政年份:2021
-
负责人:Eyal Amiel
-
依托单位:
Durable Schistosome induced metabolic alterations to the myeloid lineage
-
批准号:10559643
-
项目类别:
-
资助金额:$55.6万
-
财政年份:2021
-
负责人:Eyal Amiel
-
依托单位:
海外基金